ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Coronary Heart Disease Occluder Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-12I13327
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Coronary Heart Disease Occluder Market Research Report 2023
BUY CHAPTERS

Global Coronary Heart Disease Occluder Market Research Report 2025

Code: QYRE-Auto-12I13327
Report
May 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia Inc
MicroPort

Coronary Heart Disease Occluder Market Size

The global market for Coronary Heart Disease Occluder was valued at US$ 276 million in the year 2024 and is projected to reach a revised size of US$ 417 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Coronary Heart Disease Occluder Market

Coronary Heart Disease Occluder Market

CHD occluders are medical devices intended for the closure of the remnant opening, or a defect, in the heart resulting from congenital abnormal development.
The coronary heart disease occluder market is driven by the increasing prevalence of coronary heart disease (CHD) and the demand for minimally invasive treatment options. CHD is a leading cause of morbidity and mortality worldwide, leading to the need for effective and safe treatment devices. Coronary heart disease occluders are specialized devices used in percutaneous procedures to close or occlude abnormal openings in the heart, such as septal defects or patent foramen ovale. These occluders offer advantages over traditional surgical methods, such as reduced procedural risks, shorter hospital stays, and quicker recovery times. Moreover, advancements in medical technology and imaging techniques have improved the accuracy and success rates of these procedures, contributing to market growth. However, the market also faces challenges, including the high cost of occluder devices and the need for specialized training for healthcare professionals performing these procedures. Additionally, the stringent regulatory approval process for medical devices poses obstacles to new market entrants. To succeed, manufacturers need to focus on cost-effectiveness, continuous innovation, and collaboration with healthcare providers to improve patient outcomes and expand their presence in the coronary heart disease occluder market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coronary Heart Disease Occluder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Heart Disease Occluder.
The Coronary Heart Disease Occluder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Coronary Heart Disease Occluder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coronary Heart Disease Occluder manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Coronary Heart Disease Occluder Market Report

Report Metric Details
Report Name Coronary Heart Disease Occluder Market
Accounted market size in year US$ 276 million
Forecasted market size in 2031 US$ 417 million
CAGR 6.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical, Cardia, MicroPort
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Coronary Heart Disease Occluder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Coronary Heart Disease Occluder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Coronary Heart Disease Occluder Market growing?

Ans: The Coronary Heart Disease Occluder Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Coronary Heart Disease Occluder Market size in 2031?

Ans: The Coronary Heart Disease Occluder Market size in 2031 will be US$ 417 million.

Who are the main players in the Coronary Heart Disease Occluder Market report?

Ans: The main players in the Coronary Heart Disease Occluder Market are Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical, Cardia, MicroPort

What are the Application segmentation covered in the Coronary Heart Disease Occluder Market report?

Ans: The Applications covered in the Coronary Heart Disease Occluder Market report are Hospitals, Clinics

What are the Type segmentation covered in the Coronary Heart Disease Occluder Market report?

Ans: The Types covered in the Coronary Heart Disease Occluder Market report are ASD Occluder, VSD Occluder, PDA Occluder

Recommended Reports

Occluder Devices

Coronary Devices

Cardiac Intervention

1 Coronary Heart Disease Occluder Market Overview
1.1 Product Definition
1.2 Coronary Heart Disease Occluder by Type
1.2.1 Global Coronary Heart Disease Occluder Market Value Comparison by Type (2024 VS 2031)
1.2.2 ASD Occluder
1.2.3 VSD Occluder
1.2.4 PDA Occluder
1.3 Coronary Heart Disease Occluder by Application
1.3.1 Global Coronary Heart Disease Occluder Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Coronary Heart Disease Occluder Market Size Estimates and Forecasts
1.4.1 Global Coronary Heart Disease Occluder Revenue 2020-2031
1.4.2 Global Coronary Heart Disease Occluder Sales 2020-2031
1.4.3 Global Coronary Heart Disease Occluder Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Coronary Heart Disease Occluder Market Competition by Manufacturers
2.1 Global Coronary Heart Disease Occluder Sales Market Share by Manufacturers (2020-2025)
2.2 Global Coronary Heart Disease Occluder Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Coronary Heart Disease Occluder Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Coronary Heart Disease Occluder, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Coronary Heart Disease Occluder, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coronary Heart Disease Occluder, Product Type & Application
2.7 Global Key Manufacturers of Coronary Heart Disease Occluder, Date of Enter into This Industry
2.8 Global Coronary Heart Disease Occluder Market Competitive Situation and Trends
2.8.1 Global Coronary Heart Disease Occluder Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Coronary Heart Disease Occluder Players Market Share by Revenue
2.8.3 Global Coronary Heart Disease Occluder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Coronary Heart Disease Occluder Market Scenario by Region
3.1 Global Coronary Heart Disease Occluder Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Coronary Heart Disease Occluder Sales by Region: 2020-2031
3.2.1 Global Coronary Heart Disease Occluder Sales by Region: 2020-2025
3.2.2 Global Coronary Heart Disease Occluder Sales by Region: 2026-2031
3.3 Global Coronary Heart Disease Occluder Revenue by Region: 2020-2031
3.3.1 Global Coronary Heart Disease Occluder Revenue by Region: 2020-2025
3.3.2 Global Coronary Heart Disease Occluder Revenue by Region: 2026-2031
3.4 North America Coronary Heart Disease Occluder Market Facts & Figures by Country
3.4.1 North America Coronary Heart Disease Occluder Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Coronary Heart Disease Occluder Sales by Country (2020-2031)
3.4.3 North America Coronary Heart Disease Occluder Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Coronary Heart Disease Occluder Market Facts & Figures by Country
3.5.1 Europe Coronary Heart Disease Occluder Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Coronary Heart Disease Occluder Sales by Country (2020-2031)
3.5.3 Europe Coronary Heart Disease Occluder Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coronary Heart Disease Occluder Market Facts & Figures by Region
3.6.1 Asia Pacific Coronary Heart Disease Occluder Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Coronary Heart Disease Occluder Sales by Region (2020-2031)
3.6.3 Asia Pacific Coronary Heart Disease Occluder Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Coronary Heart Disease Occluder Market Facts & Figures by Country
3.7.1 Latin America Coronary Heart Disease Occluder Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Coronary Heart Disease Occluder Sales by Country (2020-2031)
3.7.3 Latin America Coronary Heart Disease Occluder Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Coronary Heart Disease Occluder Market Facts & Figures by Country
3.8.1 Middle East and Africa Coronary Heart Disease Occluder Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Coronary Heart Disease Occluder Sales by Country (2020-2031)
3.8.3 Middle East and Africa Coronary Heart Disease Occluder Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coronary Heart Disease Occluder Sales by Type (2020-2031)
4.1.1 Global Coronary Heart Disease Occluder Sales by Type (2020-2025)
4.1.2 Global Coronary Heart Disease Occluder Sales by Type (2026-2031)
4.1.3 Global Coronary Heart Disease Occluder Sales Market Share by Type (2020-2031)
4.2 Global Coronary Heart Disease Occluder Revenue by Type (2020-2031)
4.2.1 Global Coronary Heart Disease Occluder Revenue by Type (2020-2025)
4.2.2 Global Coronary Heart Disease Occluder Revenue by Type (2026-2031)
4.2.3 Global Coronary Heart Disease Occluder Revenue Market Share by Type (2020-2031)
4.3 Global Coronary Heart Disease Occluder Price by Type (2020-2031)
5 Segment by Application
5.1 Global Coronary Heart Disease Occluder Sales by Application (2020-2031)
5.1.1 Global Coronary Heart Disease Occluder Sales by Application (2020-2025)
5.1.2 Global Coronary Heart Disease Occluder Sales by Application (2026-2031)
5.1.3 Global Coronary Heart Disease Occluder Sales Market Share by Application (2020-2031)
5.2 Global Coronary Heart Disease Occluder Revenue by Application (2020-2031)
5.2.1 Global Coronary Heart Disease Occluder Revenue by Application (2020-2025)
5.2.2 Global Coronary Heart Disease Occluder Revenue by Application (2026-2031)
5.2.3 Global Coronary Heart Disease Occluder Revenue Market Share by Application (2020-2031)
5.3 Global Coronary Heart Disease Occluder Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Coronary Heart Disease Occluder Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Coronary Heart Disease Occluder Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Coronary Heart Disease Occluder Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Coronary Heart Disease Occluder Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 LifeTech
6.3.1 LifeTech Company Information
6.3.2 LifeTech Description and Business Overview
6.3.3 LifeTech Coronary Heart Disease Occluder Sales, Revenue and Gross Margin (2020-2025)
6.3.4 LifeTech Coronary Heart Disease Occluder Product Portfolio
6.3.5 LifeTech Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Company Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Coronary Heart Disease Occluder Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lepu Medical Coronary Heart Disease Occluder Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 Occlutech
6.5.1 Occlutech Company Information
6.5.2 Occlutech Description and Business Overview
6.5.3 Occlutech Coronary Heart Disease Occluder Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Occlutech Coronary Heart Disease Occluder Product Portfolio
6.5.5 Occlutech Recent Developments/Updates
6.6 W. L. Gore & Associates
6.6.1 W. L. Gore & Associates Company Information
6.6.2 W. L. Gore & Associates Description and Business Overview
6.6.3 W. L. Gore & Associates Coronary Heart Disease Occluder Sales, Revenue and Gross Margin (2020-2025)
6.6.4 W. L. Gore & Associates Coronary Heart Disease Occluder Product Portfolio
6.6.5 W. L. Gore & Associates Recent Developments/Updates
6.7 Starway
6.7.1 Starway Company Information
6.7.2 Starway Description and Business Overview
6.7.3 Starway Coronary Heart Disease Occluder Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Starway Coronary Heart Disease Occluder Product Portfolio
6.7.5 Starway Recent Developments/Updates
6.8 Coherex Medical
6.8.1 Coherex Medical Company Information
6.8.2 Coherex Medical Description and Business Overview
6.8.3 Coherex Medical Coronary Heart Disease Occluder Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Coherex Medical Coronary Heart Disease Occluder Product Portfolio
6.8.5 Coherex Medical Recent Developments/Updates
6.9 Cardia
6.9.1 Cardia Company Information
6.9.2 Cardia Description and Business Overview
6.9.3 Cardia Coronary Heart Disease Occluder Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cardia Coronary Heart Disease Occluder Product Portfolio
6.9.5 Cardia Recent Developments/Updates
6.10 MicroPort
6.10.1 MicroPort Company Information
6.10.2 MicroPort Description and Business Overview
6.10.3 MicroPort Coronary Heart Disease Occluder Sales, Revenue and Gross Margin (2020-2025)
6.10.4 MicroPort Coronary Heart Disease Occluder Product Portfolio
6.10.5 MicroPort Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coronary Heart Disease Occluder Industry Chain Analysis
7.2 Coronary Heart Disease Occluder Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coronary Heart Disease Occluder Production Mode & Process Analysis
7.4 Coronary Heart Disease Occluder Sales and Marketing
7.4.1 Coronary Heart Disease Occluder Sales Channels
7.4.2 Coronary Heart Disease Occluder Distributors
7.5 Coronary Heart Disease Occluder Customer Analysis
8 Coronary Heart Disease Occluder Market Dynamics
8.1 Coronary Heart Disease Occluder Industry Trends
8.2 Coronary Heart Disease Occluder Market Drivers
8.3 Coronary Heart Disease Occluder Market Challenges
8.4 Coronary Heart Disease Occluder Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia Inc
MicroPort
List of Tables
 Table 1. Global Coronary Heart Disease Occluder Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Coronary Heart Disease Occluder Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Coronary Heart Disease Occluder Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Coronary Heart Disease Occluder Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Coronary Heart Disease Occluder Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Coronary Heart Disease Occluder Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Coronary Heart Disease Occluder Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Coronary Heart Disease Occluder Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Coronary Heart Disease Occluder, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Coronary Heart Disease Occluder, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Coronary Heart Disease Occluder, Product Type & Application
 Table 12. Global Key Manufacturers of Coronary Heart Disease Occluder, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Coronary Heart Disease Occluder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Heart Disease Occluder as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Coronary Heart Disease Occluder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Coronary Heart Disease Occluder Sales by Region (2020-2025) & (K Units)
 Table 18. Global Coronary Heart Disease Occluder Sales Market Share by Region (2020-2025)
 Table 19. Global Coronary Heart Disease Occluder Sales by Region (2026-2031) & (K Units)
 Table 20. Global Coronary Heart Disease Occluder Sales Market Share by Region (2026-2031)
 Table 21. Global Coronary Heart Disease Occluder Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Coronary Heart Disease Occluder Revenue Market Share by Region (2020-2025)
 Table 23. Global Coronary Heart Disease Occluder Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Coronary Heart Disease Occluder Revenue Market Share by Region (2026-2031)
 Table 25. North America Coronary Heart Disease Occluder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Coronary Heart Disease Occluder Sales by Country (2020-2025) & (K Units)
 Table 27. North America Coronary Heart Disease Occluder Sales by Country (2026-2031) & (K Units)
 Table 28. North America Coronary Heart Disease Occluder Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Coronary Heart Disease Occluder Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Coronary Heart Disease Occluder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Coronary Heart Disease Occluder Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Coronary Heart Disease Occluder Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Coronary Heart Disease Occluder Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Coronary Heart Disease Occluder Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Coronary Heart Disease Occluder Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Coronary Heart Disease Occluder Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Coronary Heart Disease Occluder Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Coronary Heart Disease Occluder Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Coronary Heart Disease Occluder Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Coronary Heart Disease Occluder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Coronary Heart Disease Occluder Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Coronary Heart Disease Occluder Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Coronary Heart Disease Occluder Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Coronary Heart Disease Occluder Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Coronary Heart Disease Occluder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Coronary Heart Disease Occluder Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Coronary Heart Disease Occluder Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Coronary Heart Disease Occluder Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Coronary Heart Disease Occluder Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Coronary Heart Disease Occluder Sales (K Units) by Type (2020-2025)
 Table 51. Global Coronary Heart Disease Occluder Sales (K Units) by Type (2026-2031)
 Table 52. Global Coronary Heart Disease Occluder Sales Market Share by Type (2020-2025)
 Table 53. Global Coronary Heart Disease Occluder Sales Market Share by Type (2026-2031)
 Table 54. Global Coronary Heart Disease Occluder Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Coronary Heart Disease Occluder Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Coronary Heart Disease Occluder Revenue Market Share by Type (2020-2025)
 Table 57. Global Coronary Heart Disease Occluder Revenue Market Share by Type (2026-2031)
 Table 58. Global Coronary Heart Disease Occluder Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Coronary Heart Disease Occluder Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Coronary Heart Disease Occluder Sales (K Units) by Application (2020-2025)
 Table 61. Global Coronary Heart Disease Occluder Sales (K Units) by Application (2026-2031)
 Table 62. Global Coronary Heart Disease Occluder Sales Market Share by Application (2020-2025)
 Table 63. Global Coronary Heart Disease Occluder Sales Market Share by Application (2026-2031)
 Table 64. Global Coronary Heart Disease Occluder Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Coronary Heart Disease Occluder Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Coronary Heart Disease Occluder Revenue Market Share by Application (2020-2025)
 Table 67. Global Coronary Heart Disease Occluder Revenue Market Share by Application (2026-2031)
 Table 68. Global Coronary Heart Disease Occluder Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Coronary Heart Disease Occluder Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Coronary Heart Disease Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Coronary Heart Disease Occluder Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Boston Scientific Company Information
 Table 76. Boston Scientific Description and Business Overview
 Table 77. Boston Scientific Coronary Heart Disease Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boston Scientific Coronary Heart Disease Occluder Product
 Table 79. Boston Scientific Recent Developments/Updates
 Table 80. LifeTech Company Information
 Table 81. LifeTech Description and Business Overview
 Table 82. LifeTech Coronary Heart Disease Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. LifeTech Coronary Heart Disease Occluder Product
 Table 84. LifeTech Recent Developments/Updates
 Table 85. Lepu Medical Company Information
 Table 86. Lepu Medical Description and Business Overview
 Table 87. Lepu Medical Coronary Heart Disease Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Lepu Medical Coronary Heart Disease Occluder Product
 Table 89. Lepu Medical Recent Developments/Updates
 Table 90. Occlutech Company Information
 Table 91. Occlutech Description and Business Overview
 Table 92. Occlutech Coronary Heart Disease Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Occlutech Coronary Heart Disease Occluder Product
 Table 94. Occlutech Recent Developments/Updates
 Table 95. W. L. Gore & Associates Company Information
 Table 96. W. L. Gore & Associates Description and Business Overview
 Table 97. W. L. Gore & Associates Coronary Heart Disease Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. W. L. Gore & Associates Coronary Heart Disease Occluder Product
 Table 99. W. L. Gore & Associates Recent Developments/Updates
 Table 100. Starway Company Information
 Table 101. Starway Description and Business Overview
 Table 102. Starway Coronary Heart Disease Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Starway Coronary Heart Disease Occluder Product
 Table 104. Starway Recent Developments/Updates
 Table 105. Coherex Medical Company Information
 Table 106. Coherex Medical Description and Business Overview
 Table 107. Coherex Medical Coronary Heart Disease Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Coherex Medical Coronary Heart Disease Occluder Product
 Table 109. Coherex Medical Recent Developments/Updates
 Table 110. Cardia Company Information
 Table 111. Cardia Description and Business Overview
 Table 112. Cardia Coronary Heart Disease Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Cardia Coronary Heart Disease Occluder Product
 Table 114. Cardia Recent Developments/Updates
 Table 115. MicroPort Company Information
 Table 116. MicroPort Description and Business Overview
 Table 117. MicroPort Coronary Heart Disease Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. MicroPort Coronary Heart Disease Occluder Product
 Table 119. MicroPort Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Coronary Heart Disease Occluder Distributors List
 Table 123. Coronary Heart Disease Occluder Customers List
 Table 124. Coronary Heart Disease Occluder Market Trends
 Table 125. Coronary Heart Disease Occluder Market Drivers
 Table 126. Coronary Heart Disease Occluder Market Challenges
 Table 127. Coronary Heart Disease Occluder Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Coronary Heart Disease Occluder
 Figure 2. Global Coronary Heart Disease Occluder Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Coronary Heart Disease Occluder Market Share by Type: 2024 & 2031
 Figure 4. ASD Occluder Product Picture
 Figure 5. VSD Occluder Product Picture
 Figure 6. PDA Occluder Product Picture
 Figure 7. Global Coronary Heart Disease Occluder Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Coronary Heart Disease Occluder Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Clinics
 Figure 11. Global Coronary Heart Disease Occluder Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Coronary Heart Disease Occluder Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Coronary Heart Disease Occluder Sales (2020-2031) & (K Units)
 Figure 14. Global Coronary Heart Disease Occluder Average Price (US$/Unit) & (2020-2031)
 Figure 15. Coronary Heart Disease Occluder Report Years Considered
 Figure 16. Coronary Heart Disease Occluder Sales Share by Manufacturers in 2024
 Figure 17. Global Coronary Heart Disease Occluder Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Coronary Heart Disease Occluder Players: Market Share by Revenue in Coronary Heart Disease Occluder in 2024
 Figure 19. Coronary Heart Disease Occluder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Coronary Heart Disease Occluder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Coronary Heart Disease Occluder Sales Market Share by Country (2020-2031)
 Figure 22. North America Coronary Heart Disease Occluder Revenue Market Share by Country (2020-2031)
 Figure 23. United States Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Coronary Heart Disease Occluder Sales Market Share by Country (2020-2031)
 Figure 26. Europe Coronary Heart Disease Occluder Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Coronary Heart Disease Occluder Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Coronary Heart Disease Occluder Revenue Market Share by Region (2020-2031)
 Figure 34. China Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Coronary Heart Disease Occluder Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Coronary Heart Disease Occluder Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Coronary Heart Disease Occluder Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Coronary Heart Disease Occluder Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Coronary Heart Disease Occluder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Coronary Heart Disease Occluder by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Coronary Heart Disease Occluder by Type (2020-2031)
 Figure 53. Global Coronary Heart Disease Occluder Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Coronary Heart Disease Occluder by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Coronary Heart Disease Occluder by Application (2020-2031)
 Figure 56. Global Coronary Heart Disease Occluder Price (US$/Unit) by Application (2020-2031)
 Figure 57. Coronary Heart Disease Occluder Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global CHD Occluder Market Research Report 2025
Global Congenital Heart Disease Occluder Device Market Research Report 2025
Global CHD Closure Devices Market Research Report 2025
Medical Occluder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Occluder Device Market Research Report 2025
Global Medical Heart Closure Device Market Research Report 2025
Global VSD Occluder System Market Research Report 2024
Global Heart Defect Occluder Market Research Report 2025
Congenital Heart Disease Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Heart Defect Closure Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Congenital Heart Disease Occluder Market Research Report 2024
Global Heart Defects Closure Device Market Research Report 2024
Atrial Septal Occluder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ASD Occluder Device Market Research Report 2024
Global Cardiac Implant Closure Device Market Research Report 2024
Global Heart Closure Devices Market Research Report 2024
Global Diagnostic Interventional Cardiology Devices Market Insights Forecast to 2030
Global VSD Occluder Device Market Research Report 2024
Global Cardiovascular Interventional Product Market Research Report 2025
Coronary Vascular Closure Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions